THE USE OF AMD3100 FOR BONE MARROW DERIVED MESENCHYMAL STEM CELLS MOBILIZATION IN THE TREATMENT OF ASHERMAN’S SYNDROME
Flores V, Delis P, Mamillapalli R, Taylor H. THE USE OF AMD3100 FOR BONE MARROW DERIVED MESENCHYMAL STEM CELLS MOBILIZATION IN THE TREATMENT OF ASHERMAN’S SYNDROME. Fertility And Sterility 2024, 122: e36-e37. DOI: 10.1016/j.fertnstert.2024.07.168.Peer-Reviewed Original ResearchMesenchymal stem cell mobilizationTreatment of Asherman's syndromeStem cell mobilizationAsherman's syndromeCell mobilization